首页 | 官方网站   微博 | 高级检索  
     


Inter-ictal assay of peripheral circulating inflammatory mediators in migraine patients under adjunctive cervical non-invasive vagus nerve stimulation (nVNS): A proof-of-concept study
Authors:Shafqat R Chaudhry  Ilana S Lendvai  Sajjad Muhammad  Philipp Westhofen  Johannes Kruppenbacher  Lukas Scheef  Henning Boecker  Dirk Scheele  Rene Hurlemann  Thomas M Kinfe
Affiliation:1. Department of Neurosurgery, Bonn, Germany;2. University Hospital Bonn, Rheinische Friedrich-Wilhelms-University of Bonn, Germany;3. Helsinki University Hospital, Helsinki, Finland;4. Center for Hemostaseology and Transfusion Medicine, Bonn, Germany;5. Department of Radiology, Germany;6. Division of Experimental Neuroradiology, Germany;7. Department of Psychiatry, Germany;8. Division of Medical Psychology, Germany
Abstract:

Objective

To assay peripheral inter-ictal cytokine serum levels and possible relations with non-invasive vagus nerve stimulation (nVNS) responsiveness in migraineurs.

Methods

This double-blinded, sham-controlled study enrolled 48 subjects and measured headache severity, frequency headache days/month, number of total and mild/moderate/severe classified attacks/month], functional state sleep, mood, body weight, migraine-associated disability] and serum levels of inflammatory markers inter-ictal] using enzyme-linked immunoassays at baseline and after 2 months of adjunctive nVNS compared to sham stimulation and suitably matched controls.

Results

No significant differences were observed at baseline and after 2 months for headache severity, total attacks/month, headache days/month and functional outcome sleep, mood, disability] between verum and sham nVNS. However, the number of severe attacks/month significantly decreased in the verum nVNS group and circulating pro-inflammatory IL-1β was elevated significantly in the sham group compared to nVNS. Levels of anti-inflammatory IL-10 were significantly higher at baseline in both groups compared to healthy controls, but not at 2 months follow-up p?<?0.05]. Concentrations of high-mobility group box-1 (HMGB-1), IL-6, tumor-necrosis factor-α (TNF-α), leptin, adiponectin, ghrelin remained unchanged p?>?0.05]. No severe device-/stimulation-related adverse events occurred.

Conclusion

2 months of adjunctive cervical nVNS significantly declined the number of severe attacks/month. Pro-inflammatory IL-1β plasma levels inter-ictal] were higher in sham-treated migraine patients compared to verum nVNS. However, pro- IL-6, HMGB-1, TNF-α, leptin] and anti-inflammatory IL-10, adiponectin, ghrelin] mediators did not differ statistically. Profiling of neuroinflammatory circuits in migraine to predict nVNS responsiveness remains an experimental approach, which may be biased by pre-analytic variables warranting large-scale biobank-based systematic investigations omics].
Keywords:Migraine  Neuroinflammation  Vagus nerve stimulation  Trigemino-nociceptive signaling  Interleukins  Adipokines  BDI  Beck Depression Inventory  CAP  cholinergic anti-inflammatory pathway  CGRP  Calcitonin gene related peptide  CM  chronic migraine  CRP  C-reactive protein  DAMP  damage associated molecular patterns  ELISA  enzyme-linked immunoassay  EM  episodic migraine  HMGB  high mobility group box  IL  interleukins  TNF  tumor necrosis factor  IHS  International Headache Society  MIDAS  migraine disability scale  nVNS  cervical non-invasive vagal nerve stimulation  PSQI  Pittsburgh Sleep Quality Inventory
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号